The Ohio Third Frontier Commission last week announced that it has awarded six public-private research groups a total of $23 million through the Ohio Biomedical Research Commercialization Program to help commercialize promising biomedical technologies.
For the second time in the history of the 5-year-old program an Ohio-based life-sciences company will lead one of the grants. The OBRCP has traditionally named a university or non-profit research institution to head funded projects.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.
A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.
Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.
In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.